Externalizing Astellas

Astellas' new R&D strategy focused on growing preclinical pipeline

With a stocked late-stage pipeline, Astellas has turned its attention to growing its early-stage pipeline with a focus on external partnerships over traditional bricks-and-mortar R&D.

• Building the Astellas pipeline

Trino: Planting GI health

Trino has new class of anti-inflammatory compounds for ulcerative colitis

Trino spun out of Trinity College Dublin with a portfolio of novel anti-inflammatory compounds that have shown potential in preclinical models of ulcerative colitis.

• Sidebar: Corporate Profile

The sky isn't falling

SCOTUS-Myriad protects biotech patenting, but leaves important gray areas

The Supreme Court's Myriad ruling looks to be a net win for biotech companies now. But it did not draw a bright line to determine how close a potential invention can come to a naturally occurring phenomenon.